News

PharmiWeb2h
Medical Care Technologies (OTC: MDCE) Unveils Bold Vision for Mobile Self-Care Innovation
MDCE Launches Official Site MESA, AZ / ACCESS Newswire / July 7, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a health technology company focused on AI-powered self-care and mobile ...
PharmiWeb2h
MediQuant Expands DataArk(R) Platform to Support Ambulatory Facilities with Launch of CommunityArk(TM)
The new module delivers a cost-effective, secure, robust data archive for small hospitals and ambulatory providers. INDEPENDENCE, OH / ACCESS Newswire / July 7, 2025 / MediQuant, LLC, a leader in ...
PharmiWeb2h
Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape
AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory AutomationPartnership Accelerates AI Scent Intelligence Deployment in Semiconductors, Robotics and More SAN ...
PharmiWeb2h
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements
STONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received ...
PharmiWeb3h
MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
HALIFAX, NS / ACCESS Newswire / July 7, 2025 / MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate ...
PharmiWeb3h
ALS Community Files Citizens’ Petition asking FDA to Approve NurOwn Stem Cell Therapy
New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live Stronger BREMERTON, WA / ACCESS Newswire / July 7, 2025 / On July 4, 1939, ...
PharmiWeb5h
Monthly Update June - New Share Issue, Shareholder Campaign, and Continued International Growth
STOCKHOLM, SE / ACCESS Newswire / July 7, 2025 / iZafe Group (STO:IZAFE-B) - Strong Start to the Summer - and Continued Focus on Reaching 10 MSEK in ARRJune was marked by strategic initiatives and a ...
PharmiWeb6h
Global Biopreservation Market Valuation and Growth Forecast to 2035
The global Biopreservation Market is valued at USD 7.11 billion in 2024 and is projected to reach a value of USD 37.76 ...
PharmiWeb6h
Generative AI in Healthcare Market Growing at 36–38% CAGR Amid Demand for Precision Care by 2029
The Global Generative Artificial Intelligence (GenAI) in Healthcare Market is expected to witness a growth rate of 36-38% in ...
PharmiWeb6h
Multi-omics Market forecast to expand at 16% CAGR backed by genomics and cancer research by 2029
The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...
PharmiWeb6h
Alzheimer’s Drugs Market to witness 20% CAGR due to increased diagnosis and drug innovation by 2029
The Alzheimer’s Drugs Market is anticipated to experience a compound annual growth rate (CAGR) of approximately 20% over the ...
PharmiWeb7h
BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase
VANCOUVER, BC / ACCESS Newswire / July 7, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:XPHYF)(FSE:4XT), a bioscience innovator specializing in advanced drug delivery systems ...